Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News Restaurant Industry News FDA accepts Ascendis Pharma’s TransCon hGH BLA for pediatric GHD Ascendis Pharma, a Danish biopharma company, said that the US Food and Drug Administration (FDA) has accepted its… bypharmanewsdailySeptember 4, 2020
